This S&P 500 Stock Is Surprisingly the Best Performer This Year

One pharmaceutical company is outperforming all S&P 500 stocks. Regeneron has made a massive surge over the last three months as the company continues to develop a possible COVID-19 treatment. Equity analysts believe that the stock has more upside potential. While popular COVID-19 bets such as Amazon (NASDAQ:AMZN) and Netflix (NASDAQ:NFLX) have taken center stage, …